Physician profile
Scott A Sample
NPI 1558444216
$5,233.53
in general payments reported to CMS, 2019-2025
29 companies · $1,137 in 2025
The $1,137 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $387 · 2020: $159 · 2021: $617 · 2022: $804 · 2023: $1,180 · 2024: $949 · 2025: $1,137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,383 · Consulting Fee: $530 · Travel and Lodging: $353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,382.76 |
| Consulting Fee | $530.00 |
| Travel and Lodging | $353.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,675.47 | 2019-2025 | Watchman Flx, Watchman Access System, Eluvia |
| Edwards Lifesciences Corporation | $1,013.77 | 2020-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $719.62 | 2023-2025 | Amplatzer Amulet, Amplatzer Talisman, Diamondback Coronary |
| Abiomed | $608.16 | 2021-2025 | Impella |
| Medtronic, INC. | $172.47 | 2022-2025 | Corevalve Evolut R, Tyrx, Linq II |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $141.09 | 2020-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $117.36 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $113.00 | 2023-2024 | Camzyos, Eliquis |
| Acacia Pharma INC | $100.01 | 2021 | |
| Merck Sharp & Dohme LLC | $71.05 | 2022-2024 | Winrevair, Verquvo |
| Angiodynamics, INC. | $52.90 | 2022-2025 | Auryon Laser System 100-120 Vac |
| Baxter Healthcare | $51.46 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Cardiovascular Systems INC. | $43.90 | 2020-2022 | |
| Philips North America LLC | $35.12 | 2020-2025 | Coronary Other |
| Pfizer INC. | $34.69 | 2023-2024 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $32.90 | 2022-2025 | Manta |
| Novartis Pharmaceuticals Corporation | $30.91 | 2021-2023 | |
| Novo Nordisk INC | $30.41 | 2021 | |
| Atricure, INC. | $26.21 | 2021-2022 | |
| Terumo Medical Corporation | $23.83 | 2023 | Tr Band |
| Esperion Therapeutics, INC. | $19.01 | 2021 | |
| Shockwave Medical, INC | $17.81 | 2025 | |
| Chiesi USA, INC. | $15.66 | 2020 | |
| Alnylam Pharmaceuticals INC. | $15.62 | 2022 | |
| Medtronic Vascular, INC. | $15.58 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.43 | 2024 | Jardiance |
| Amgen INC. | $14.24 | 2025 | Repatha |
| Biosense Webster, INC. | $13.47 | 2021 | |
| Irhythm Technologies, INC. | $12.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Sample listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.